Depreciation of INOVIO PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
INOVIO PHARMACEUTICALS, INC. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • INOVIO PHARMACEUTICALS, INC. Depreciation for the quarter ending 31 Mar 2025 was $371,367, a 13% decline year-over-year.
  • INOVIO PHARMACEUTICALS, INC. annual Depreciation for 2025 was $1,417,913, a 19% decline from 2024.
  • INOVIO PHARMACEUTICALS, INC. annual Depreciation for 2024 was $1,752,147, a 33% decline from 2023.
  • INOVIO PHARMACEUTICALS, INC. annual Depreciation for 2023 was $2,621,649, a 28% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

INOVIO PHARMACEUTICALS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,417,913 -$334,234 -19% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $1,752,147 -$869,502 -33% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $2,621,649 -$1,035,064 -28% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $3,656,713 +$616,617 +20% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 $3,040,096 +$1,100 +0.04% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024 2023 FY
2020 $3,038,996 -$559,392 -16% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $3,598,388 -$148,795 -4% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $3,747,183 +$1,896,807 +103% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $1,850,376 +$141,878 +8.3% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $1,708,498 +$660,067 +63% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019 2018 FY
2015 $1,048,431 +$421,877 +67% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $626,554 +$297,802 +91% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $328,752 +$155,002 +89% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
2012 $173,750 +$31,553 +22% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $142,197 -$52,432 -27% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
2010 $194,629 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY

INOVIO PHARMACEUTICALS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $371,367 -$53,106 -13% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $424,473 -$282,905 -40% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $707,378 -$222,005 -24% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $929,383 +$268,686 +41% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $660,697 -$148,862 -18% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $809,559 -$121,348 -13% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $930,907 +$33,198 +3.7% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $897,709 +$375,411 +72% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $522,298 +$134,431 +35% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $387,867 +$173,873 +81% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $213,994 +$98,477 +85% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $115,517 +$75,676 +190% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $39,841 +$3,025 +8.2% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $36,816 +$4,480 +14% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $32,336 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.